文献速递重症综合管理与镇静镇痛心脑血管急症消化、代谢与肾脏急症

早期高敏肌钙蛋白升高与脓毒症短期死亡率:系统评价与Meta分析

Early high-sensitivity troponin elevation and short-term mortality in sepsis: a systematic review with meta-analysis.
PubMed 文献 · Crit Care · 2025-02-14
一句话结论脓毒症患者早期高敏肌钙蛋白升高与短期死亡率相关,但校正混杂因素后并非独立关联(aOR=1.06,95%CI 0.99-1.14)。

该系统评价纳入17项研究、6242例符合Sepsis-3定义的成人脓毒症患者,短期死亡率为16.9%至53.8%。 crude分析显示,死亡者高敏肌钙蛋白高于存活者(SMD=0.87,95%CI 0.41-1.33),高敏肌钙蛋白升高与死亡率增加相关(OR=1.78,95%CI 1.41-2.25)。但在校正不同混杂因素的研究中,这一预后效应消失(aOR=1.06,95%CI 0.99-1.14)。提示高敏肌钙蛋白升高在脓毒症中并非独立预后因素。

要点

  • 在6242例成人脓毒症患者中,死亡者早期高敏肌钙蛋白水平高于存活者(SMD=0.87,95%CI 0.41-1.33)。
  • 未校正分析显示高敏肌钙蛋白升高与短期死亡率增加相关(OR=1.78,95%CI 1.41-2.25)。
  • 在校正混杂因素的研究中,高敏肌钙蛋白升高与死亡率无独立关联(aOR=1.06,95%CI 0.99-1.14)。
  • 纳入研究的短期死亡率为16.9%至53.8%。
  • 高敏肌钙蛋白升高不应单独用于脓毒症预后判断。

适用人群与场景

  • 符合Sepsis-3定义的成人脓毒症患者。

诊断标准与关键阈值

  • 脓毒症诊断采用Sepsis-3定义。

研究设计与关键结果

  • 系统评价纳入17项研究、共6242例成人脓毒症患者,短期死亡率为16.9%至53.8%。
  • 死亡者高敏肌钙蛋白高于存活者,SMD=0.87(95%CI 0.41-1.33)。
  • 高敏肌钙蛋白升高与死亡率增加相关,OR=1.78(95%CI 1.41-2.25)。
  • 在校正不同混杂因素的研究中,高敏肌钙蛋白升高与死亡率无独立关联,aOR=1.06(95%CI 0.99-1.14)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,高敏肌钙蛋白升高与脓毒症短期死亡率风险增加相关,但并非独立相关;原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Serum cardiac troponin (cTn) elevation is a well-established phenomenon in sepsis. However, the clinical significance of this phenomenon with high-sensitivity (hs) assays and the current sepsis definition needs to be settled.

RESEARCH QUESTION: What is the association between early serum cTn levels measured by hs-assays and the risk of short-term mortality in septic patients?

STUDY DESIGN AND METHODS: We conducted a systematic review using a comprehensive PubMed, Scopus, and Embase search. Studies were eligible if they reported association data on early hs-cTn and mortality in an adult sample with sepsis that met the Sepsis-3 definition. For the synthesis of the effect of hs-cTn on mortality, we applied random effect models on the pooled unadjusted and adjusted odds ratio (OR and aOR, respectively) of elevated vs. normal hs-cTn serum values, and on the crude standardized mean difference (SMD) of hs-cTn between survivors and non-survivors.

RESULTS: In total, 6242 patients from 17 studies were included, with short-term mortality rates ranging from 16.9% to 53.8%. Using a crude analysis, non-survivor patients showed higher hs-cTn than survivors (SMD of 0.87, 95%CI: 0.41-1.33). Elevated hs-cTn was associated with increased mortality (OR = 1.78, 95% CI: 1.41-2.25). However, this prognostic effect was absent in studies that adjusted for different confounders (aOR = 1.06, 95% CI: 0.99-1.14).

DISCUSSION AND CONCLUSIONS: Non-survivors of sepsis exhibited significantly elevated hs-cTn levels. While elevated hs-cTn levels are associated with an increased risk of mortality, they are not independently associated with this outcome in sepsis.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Gajardo AIJ, Ferrière-Steinert S, Valenzuela Jiménez J, et al. Early high-sensitivity troponin elevation and short-term mortality in sepsis: a systematic review with meta-analysis. Crit Care. 2025. PMID: 39953561. doi:10.1186/s13054-025-05249-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。